← Brands in the News company

ADMA Biologics, Inc.

Narrative intelligence for ADMA Biologics, Inc.: 6 tracked articles, claims, and spin patterns across AI and technology coverage.

SPIN Processed Press Release Frame: The Fog

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

A law firm has filed a class action securities lawsuit against ADMA Biologics, Inc., alleging material misrepresentations or omissions in connection with its public statements, with an August 10, 2026 application deadline for investor participation.

Spin 65% Claim Present in Source AI Risk Moderate

PR Newswire Technology

Aug 1, 2026

SPIN Processed Press Release Frame: The Fog

ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA

A shareholder litigation alert announces a pending securities class action lawsuit against ADMA Biologics, Inc., with a deadline for investors to apply to serve as lead plaintiff.

Spin 10% Claim Present in Source

PR Newswire Technology

Jul 25, 2026

SPIN Processed Press Release Frame: The Fog

ADMA Deadline: ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm

A law firm announced a securities fraud class-action lawsuit against ADMA Biologics, Inc., inviting investors who bought shares during a specified period to join the suit.

Spin 40% Claim Present in Source AI Risk Moderate

PR Newswire Technology

Jul 18, 2026

SPIN Processed Press Release Frame: The Shield

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

A law firm has issued a notice alerting investors to an upcoming deadline to join a class action securities lawsuit against ADMA Biologics, Inc., a biopharmaceutical company, over alleged misrepresentations or omissions affecting stock value.

Spin 85% Claim Present in Source

PR Newswire Technology

Jul 18, 2026

SPIN Processed Press Release Frame: The Shield

NASDAQ: ADMA CLASS ACTION NOTICE: Berger Montague Encourages ADMA Biologics, Inc. (NASDAQ: ADMA) Investors to Inquire About a Securities Fraud Class Action

A securities class action lawsuit has been filed against ADMA Biologics, Inc. alleging material misrepresentations or omissions in disclosures that allegedly misled investors about the company's financial condition and business prospects.

Spin 40% Claim Present in Source AI Risk Moderate

PR Newswire Financial Services

Jul 16, 2026

SPIN Processed Press Release Frame: The Fog

ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA

A shareholder litigation alert announces a deadline for investors to apply for lead plaintiff status in a class action lawsuit against ADMA Biologics, signaling material legal risk and potential financial liability stemming from alleged securities law violations.

Spin 20% Claim Present in Source

PR Newswire Technology

Jul 11, 2026

Related Claims

01 ADMA Biologics, Inc. made material misrepresentations or omissions in connection with its public statements.

Markdown (.md) · JSON-LD schema (.json) · Machine-readable for AI & GEO